Wesley Day

4.0k total citations · 3 hit papers
58 papers, 2.8k citations indexed

About

Wesley Day is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Surgery. According to data from OpenAlex, Wesley Day has authored 58 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Pharmacology and 11 papers in Surgery. Recurrent topics in Wesley Day's work include Pharmacology and Obesity Treatment (11 papers), Sexual function and dysfunction studies (7 papers) and Hormonal and reproductive studies (7 papers). Wesley Day is often cited by papers focused on Pharmacology and Obesity Treatment (11 papers), Sexual function and dysfunction studies (7 papers) and Hormonal and reproductive studies (7 papers). Wesley Day collaborates with scholars based in United States, United Kingdom and Austria. Wesley Day's co-authors include Craig A. Peterson, Michael Schwiers, David B. Allison, Kishore M. Gadde, Donna H. Ryan, Barbara Troupin, W. Timothy Garvey, Charles H. Bowden, Michelle Look and PETER Y. TAM and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Wesley Day

50 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial

2011 724 citations Kishore M. Gadde, David B. Allison et al. profile →
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

2011 501 citations W. Timothy Garvey, Donna H. Ryan et al. American Journal of Clinical Nutrition profile →
Controlled‐Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)

2011 486 citations David B. Allison, Kishore M. Gadde et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wesley Day United States	19	1.6k	1.6k	949	335	330	58	2.8k
Olivier Ziegler France	30	1.5k 0.9×	1.2k 0.8×	1.1k 1.2×	65 0.2×	1.0k 3.2×	145	4.1k
Sue D. Pedersen Canada	21	1.5k 0.9×	3.0k 1.9×	1.0k 1.1×	75 0.2×	980 3.0×	49	4.2k
Mark Boldrin United States	16	2.2k 1.4×	1.9k 1.2×	1.3k 1.3×	49 0.1×	582 1.8×	22	3.5k
Domenica Rubino United States	23	1.6k 1.0×	2.3k 1.5×	989 1.0×	38 0.1×	567 1.7×	60	3.4k
Michael EJ Lean United Kingdom	12	446 0.3×	743 0.5×	413 0.4×	48 0.1×	226 0.7×	22	1.6k
Charles Lucas United States	20	1.3k 0.8×	1.4k 0.9×	890 0.9×	29 0.1×	382 1.2×	58	2.9k
Christine B. Jensen Denmark	22	1.8k 1.1×	2.5k 1.6×	1.5k 1.6×	31 0.1×	898 2.7×	26	4.2k
Paula M. Hale United States	19	1.4k 0.9×	3.4k 2.2×	708 0.7×	41 0.1×	1.2k 3.7×	43	4.2k
Cyrus Desouza United States	29	206 0.1×	1.3k 0.8×	449 0.5×	215 0.6×	450 1.4×	108	2.8k
P. R. Sundaresan United States	24	404 0.3×	347 0.2×	384 0.4×	225 0.7×	113 0.3×	72	1.9k

Countries citing papers authored by Wesley Day

Since Specialization

Citations

This map shows the geographic impact of Wesley Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wesley Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wesley Day more than expected).

Fields of papers citing papers by Wesley Day

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wesley Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wesley Day. The network helps show where Wesley Day may publish in the future.

Co-authorship network of co-authors of Wesley Day

This figure shows the co-authorship network connecting the top 25 collaborators of Wesley Day. A scholar is included among the top collaborators of Wesley Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wesley Day. Wesley Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dhodapkar, Meera M., Scott J. Halperin, Wesley Day, et al.. (2025). Outcomes following single level posterior lumbar fusion in patients with systemic and discoid lupus: A retrospective national database study. North American Spine Society Journal (NASSJ). 22. 100604–100604. 1 indexed citations

Day, Wesley, et al.. (2025). Risk factors for perioperative nerve injury associated with total knee arthroplasty: Analysis of a national administrative database. PLoS ONE. 20(6). e0324527–e0324527. 1 indexed citations

Day, Wesley, et al.. (2025). Academic Orthopaedic Surgeon Financial Compensation in the United States: Trends and Distribution. JAAOS Global Research and Reviews. 9(5).

Day, Wesley, et al.. (2024). P116. National trends and risk factors for new-onset depression following posterior lumbar fusion. The Spine Journal. 24(9). S119–S119. 1 indexed citations

Gouzoulis, Michael J., et al.. (2024). Inflammatory bowel disease is associated with greater odds of complications following posterior lumbar fusion and further amplified for patients exposed to monoclonal antibody biologics. North American Spine Society Journal (NASSJ). 20. 100574–100574.

Day, Wesley, et al.. (2024). Risk Factors for Perioperative Nerve Injury Related to Total Hip Arthroplasty. Arthroplasty Today. 28. 101440–101440. 1 indexed citations

Day, Wesley, et al.. (2024). Emergency department utilization after elbow arthroscopy. JSES International. 8(4). 910–914.

Gouzoulis, Michael J., et al.. (2024). The incidence, providers involved, and patient factors associated with diagnosis of specific lumbar spine pathology subsequent an initial nonspecific low back pain diagnosis. The Spine Journal. 25(4). 688–695. 1 indexed citations

Gouzoulis, Michael J., et al.. (2024). Rate and risk factors for inpatient falls following single-level posterior lumbar fusion: A national registry study. North American Spine Society Journal (NASSJ). 20. 100549–100549. 1 indexed citations

10.

Day, Wesley, et al.. (2023). Total Hip Arthroplasty in Patients Who Have Marfan Syndrome: Adverse Events and 5-Year Revision Rates. The Journal of Arthroplasty. 39(9). S275–S278. 5 indexed citations

11.

Day, Wesley, et al.. (2023). The correlation of psoriasis and its treatment medications with lumbar discectomy postoperative infections. The Spine Journal. 23(11). 1623–1629. 9 indexed citations

12.

Day, Wesley, et al.. (2022). Assessing the Quality of YouTube Videos on Adhesive Capsulitis. Cureus. 14(7). e27406–e27406. 12 indexed citations

13.

Garvey, W. Timothy, Donna H. Ryan, Robert R. Henry, et al.. (2013). Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release. Diabetes Care. 37(4). 912–921. 134 indexed citations

14.

Goldstein, Irwin, Andrew McCullough, LeRoy Jones, et al.. (2012). A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Avanafil in Subjects with Erectile Dysfunction. The Journal of Sexual Medicine. 9(4). 1122–1133. 73 indexed citations

15.

Goldstein, Irwin, LeRoy Jones, Laurence Belkoff, et al.. (2012). Avanafil for the Treatment of Erectile Dysfunction: A Multicenter, Randomized, Double-Blind Study in Men With Diabetes Mellitus. Mayo Clinic Proceedings. 87(9). 843–852. 68 indexed citations

16.

Garvey, W. Timothy, Donna H. Ryan, Michelle Look, et al.. (2011). Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. American Journal of Clinical Nutrition. 95(2). 297–308. 501 indexed citations breakdown →

17.

Davidson, Michael H., Charles H. Bowden, & Wesley Day. (2011). WEIGHT LOSS AND CARDIOVASCULAR RISK REDUCTION OVER 2 YEARS WITH CONTROLLED-RELEASE PHENTERMINE-TOPIRAMATE. Journal of the American College of Cardiology. 57(14). E545–E545. 5 indexed citations

18.

McClung, Michael R., Ethel S. Siris, Steve Cummings, et al.. (2006). Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene. Menopause The Journal of The North American Menopause Society. 13(3). 377–386. 77 indexed citations

19.

Guzmán-Pérez, Angel, Ronald T. Wester, Mary C. Allen, et al.. (2001). Discovery of zoniporide: A potent and selective sodium–hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility. Bioorganic & Medicinal Chemistry Letters. 11(6). 803–807. 75 indexed citations

20.

Day, Wesley & Myron Weiner. (1991). Inhibition of hepatic drug metabolism and carbon tetrachloride toxicity in Fischer-344 rats by exercise. Biochemical Pharmacology. 42(1). 181–184. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact